Sono Motion
San Mateo, US · Washington corporation · 1 known investors
SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners. The company focuses on less invasive stone management technologies and has advanced these through clinical trials and regulatory efforts.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.4M disclosed across 4 rounds · 2016–2022
▶$11.5MraisedApr 2022 · 4 investors · BiotechnologyRule 506(b)
- Takashi FukuyamaDirector
- Abel AngDirector
- Michael BaileyDirector
- Oren LevyExecutive Officer, Director, Promoter
- Jeff BarnesDirector
- Offering amount
- $14.4M
- Amount sold
- $11.5M
- First sale
- Apr 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.3MraisedApr 2019 · 3 investors · Other TechnologyRule 506(b)
- Jeff BarnesDirector
- Oren LevyExecutive Officer, Director, Promoter
- Michael BaileyDirector
- Takashi FukuyamaDirector
- Offering amount
- $17.5M
- Amount sold
- $3.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$4.5MraisedApr 2017 · 3 investors · Other TechnologyRule 506(b)
- Michael BaileyDirector
- Oren LevyExecutive Officer, Director, Promoter
- Takashi FukiyamaDirector
- Jeff BarnesDirector
- Offering amount
- $4.6M
- Amount sold
- $4.5M
- First sale
- Apr 2017
- Incorporated
- Corporation, Washington, 2012
- Federal exemptions
- 06b
▶$100KraisedJul 2016 · 2 investors · Other TechnologyRule 506(b)
- Paul Douglas CorlExecutive Officer
- Oren LevyExecutive Officer, Director
- Michael BaileyExecutive Officer, Director
- Barbrina DunmireDirector
- Offering amount
- $500K
- Amount sold
- $100K
- First sale
- Jul 2016
- Incorporated
- Corporation, Washington, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Sono Motion for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $400K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $999.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $207.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $961.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sono Motion do?
- SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners. The company focuses on less invasive stone management technologies and has advanced these through clinical trials and regulatory efforts.
- Who founded Sono Motion?
- Sono Motion was founded by Oren Levy.
- Who are Sono Motion's investors?
- Sono Motion's investors include Bioventures Investors.
- How much funding has Sono Motion raised?
- Sono Motion has disclosed $19.4M raised across 4 rounds.
- Where is Sono Motion headquartered?
- Sono Motion is headquartered in San Mateo, US.